Obesity: Metabolically healthy obesity and NAFLD

Nature Reviews Gastroenterology and Hepatology

Volumn 13, Issue 8, 2016, Pages 442-444

  Targher, Giovanni ^a   Byrne, Christopher D ^b,c  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERIAL WALL THICKNESS; BODY FAT; BODY MASS; CARDIOMETABOLIC RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; CHRONIC LIVER DISEASE; COMORBIDITY; DISEASE ASSOCIATION; ECHOGRAPHY; ETHNICITY; FAT MASS; GROUPS BY AGE; HUMAN; INCIDENCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIVER CELL CARCINOMA; METABOLIC SYNDROME X; METABOLICALLY HEALTHY OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBESITY; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SHORT SURVEY; WEIGHT GAIN; METABOLICALLY BENIGN OBESITY;

BODY MASS INDEX; HUMANS; METABOLIC SYNDROME; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; OBESITY, METABOLICALLY BENIGN;

EID: 84976386636     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2016.104     Document Type: Short Survey

References (10)

1. Chang Y, et al. Metabolically healthy obesity and the development of nonalcoholic fatty liver disease. Am. J. Gastroenterol. http: //dx.doi.org/10.1038/.ajg.2016.178 (2016).
2. Bergman R. N, et al. Abdominal obesity: role in the pathophysiology of metabolic disease and cardiovascular risk. Am. J. Med. 120, S3-S8 (2007).
3. Kramer C. K, Zinman B, & Retnakaran R. Are metabolically healthy overweight and obesity benign conditions?: A systematic review and meta-Analysis. Ann. Intern. Med. 159, 758-769 (2013).
4. Roberson L. L, et al. Beyond BMI: the 'metabolically healthy obese' phenotype and its association with clinical/.subclinical cardiovascular disease and all-cause mortality - A systematic review. BMC. Public Health 14, 14 (2014).
5. Ortega F. B, et al. The intriguing metabolically healthy but obese phenotype: cardiovascular prognosis and role of fitness. Eur. Heart. J. 34, 389-397 (2013).
6. Stefan N, et al. Identification and characterization of metabolically benign obesity in humans. Arch. Intern. Med. 168, 1609-1616 (2008).
7. Byrne C. D, & Targher G. NAFLD: a multisystem disease. J. Hepatol. 62, S47-S64 (2015).
8. Sung K. C, Cha S. C, Sung J. W, So M. S, & Byrne C. D. Metabolically healthy obese subjects are at risk of fatty liver but not pre-clinical atherosclerosis. Nutr. Metab. Cardiovasc. Dis. 24, 256-262 (2014).
9. Aune D, et al. Body mass index and all-cause mortality: a systematic review and nonlinear dose response meta-Analysis of 230 prospective studies with 3.74 million deaths among 30.3 million participants. BMJ 353, i2156 (2016).
10. Afzal S, Tybjrg-Hansen A, Jensen G. B, & Nordestgaard B. G. Change in body mass index associated with lowest mortality in Denmark, 1976-2013. JAMA 315, 1989-1996 (2016).